
Functional studies of CYP21A2 mutants complement structural and clinical predictions of disease severity in CAH
2011; Wiley; Volume: 76; Issue: 5 Linguagem: Inglês
10.1111/j.1365-2265.2011.04275.x
ISSN1365-2265
AutoresMichela Barbaro, Fernanda Caroline Soardi, Maricilda Palandi de Mello, Anna Wedell, Svetlana Lajić,
Tópico(s)Hormonal Regulation and Hypertension
ResumoClinical EndocrinologyVolume 76, Issue 5 p. 766-768 LETTERS TO THE EDITOR Functional studies of CYP21A2 mutants complement structural and clinical predictions of disease severity in CAH Michela Barbaro, Michela Barbaro Department of Molecular Medicine and Surgery, Karolinska Institutet Center for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, SwedenSearch for more papers by this authorFernanda C. Soardi, Fernanda C. Soardi Department of Molecular Medicine and Surgery, Karolinska Institutet Laboratorio de Genetica Molecular Humana, Centro de Biologia Molecular e Engenharia Genetica, Universidade Estadual de Campinas, Campinas SP, Brasil E-mail: svetlana.lajic@ki.seSearch for more papers by this authorMaricilda Palandi de Mello, Maricilda Palandi de Mello Laboratorio de Genetica Molecular Humana, Centro de Biologia Molecular e Engenharia Genetica, Universidade Estadual de Campinas, Campinas SP, Brasil E-mail: svetlana.lajic@ki.seSearch for more papers by this authorAnna Wedell, Anna Wedell Department of Molecular Medicine and Surgery, Karolinska Institutet Center for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, SwedenSearch for more papers by this authorSvetlana Lajic, Svetlana Lajic Department of Molecular Medicine and Surgery, Karolinska InstitutetSearch for more papers by this author Michela Barbaro, Michela Barbaro Department of Molecular Medicine and Surgery, Karolinska Institutet Center for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, SwedenSearch for more papers by this authorFernanda C. Soardi, Fernanda C. Soardi Department of Molecular Medicine and Surgery, Karolinska Institutet Laboratorio de Genetica Molecular Humana, Centro de Biologia Molecular e Engenharia Genetica, Universidade Estadual de Campinas, Campinas SP, Brasil E-mail: svetlana.lajic@ki.seSearch for more papers by this authorMaricilda Palandi de Mello, Maricilda Palandi de Mello Laboratorio de Genetica Molecular Humana, Centro de Biologia Molecular e Engenharia Genetica, Universidade Estadual de Campinas, Campinas SP, Brasil E-mail: svetlana.lajic@ki.seSearch for more papers by this authorAnna Wedell, Anna Wedell Department of Molecular Medicine and Surgery, Karolinska Institutet Center for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, SwedenSearch for more papers by this authorSvetlana Lajic, Svetlana Lajic Department of Molecular Medicine and Surgery, Karolinska InstitutetSearch for more papers by this author First published: 31 October 2011 https://doi.org/10.1111/j.1365-2265.2011.04275.xCitations: 3Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume76, Issue5May 2012Pages 766-768 RelatedInformation
Referência(s)